QD Clinics – Still’s or Not – Part 2

Articles
Stills Dz Rx w/ IL-1 or IL-6 inhib may mask Dx of MAS! Study of 162 systemic JIA & MAS (62 on biologics). Biologic Rx pts had lower Plt, Ferritin (1107 vs 2863(, CRP (15 vs 90), ESR, fever duration. 27% on IL1/IL6i did not meetMAS classification criteria https://t.co/RmAzxh459R https://t.co/SXroqNBLSZ Fever of Unknown Origin: Not Always an Infection
Roel Sanchez Baez, MD presents his poster at RWCS 2024.
https://t.co/WiDfcNHuNv https://t.co/gTs78QmE2A PAPA (pyogenic arthritis, pyoderma gangrenosum & acne) syndrome is a hereditary autoinflammatory Dz caused by dominant mutation in PSTPIP1 (triggers IFN-γ-mediated pyrin induction & IL-18 release; can be Tx by JAK inhibition) https://t.co/fy0MnwDA5U https://t.co/l8n2EwgV0t
Join our experts, Drs Liebowitz and Mehta, as they provide insights on the differential diagnosis and management concepts in autoinflammatory diseases.
https://t.co/r5WjYIdmaT https://t.co/gGdhyDKqtC TO THE NEW MONTHLY EMAIL
Videos
ANA Pollution (2.06.2026)
DERM on RheumNow PODCAST (January 2026)
2025 Rheumatology Year in Review
Depression and RA (3.8.2024)
Podcast
An Expert Perspective on Polygenic Autoinflammatory Diseases Sponsored By Novartis Pharmaceuticals Corporation

Managing Monogenic Autoinflammatory Diseases- What Rheumatologists Need to Know – Sponsored by Novartis Pharmaceuticals Corporation

Hemophagocytic Lymphohistiocytosis in Still’s disease

June 2023 EULAR 2023 Stills Updates

Sign up
Still’s Disease & Autoinflammatory

View all news for specific disease states
Social